ICS Global Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield75.11%

Receive ICS News and Ratings via Email

Sign-up to receive the latest news and ratings for ICS Global and its competitors with MarketBeat's FREE daily newsletter.

About ICS Global

ICS Global Limited, an investment holding company, provides medical billing services primarily in the United Kingdom. The company offers medical billing and collection services to medical consultants and specialists. The company was founded in 1999 and is based in Sydney, Australia.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.27 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

ICS Global (ASX:ICS) Frequently Asked Questions

What stocks does MarketBeat like better than ICS Global?

Wall Street analysts have given ICS Global a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ICS Global wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How often does ICS Global pay dividends? What is the dividend yield for ICS Global?

ICS Global declared a Interim dividend on Thursday, July 8th. Shareholders of record on Monday, July 19th will be given a dividend of 0.23 per share on Monday, July 19th. This represents a yield of 10.5%. The ex-dividend date of this dividend is Sunday, July 11th. This is a boost from ICS Global's previous Interim dividend of A$0.05.
View ICS Global's dividend history

Is ICS Global a good dividend stock?

ICS Global pays an annual dividend of A$1.65 per share and currently has a dividend yield of 75.11%. ICS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of ICS Global is 102.42%. Payout ratios above 75% are not desirable because they may not be sustainable.
View ICS Global's dividend history.

Who are ICS Global's key executives?

ICS Global's management team includes the following people:
  • Mr. Garry Chapman, Exec. Chairman & MD of Medical Billing Service
  • Mr. Gregory James Quirk, Company Sec. & Independent Non-Exec. Director

Who are some of ICS Global's key competitors?

What is ICS Global's stock symbol?

ICS Global trades on the ASX under the ticker symbol "ICS."

How much money does ICS Global make?

ICS Global has a market capitalization of $0.00 and generates $849.00 in revenue each year.

What is ICS Global's official website?

The official website for ICS Global is

How can I contact ICS Global?

The company can be reached via phone at 61 2 8073 7888.

This page was last updated on 9/17/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.